MLN8054

DRUG2 trials

Sponsors

Millennium Pharmaceuticals, Inc.

Conditions

Advanced MalignanciesBladder NeoplasmBreast NeoplasmColon NeoplasmPancreatic Neoplasm

Phase 1

A Study of MLN8054 in Patients With Advanced Solid Tumors

TerminatedNCT00249301

Millennium Pharmaceuticals, Inc.Bladder Neoplasm, Breast Neoplasm, Colon Neoplasm +1

Start: 2005-10-31Updated: 2008-04-01

A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies

TerminatedNCT00652158

Millennium Pharmaceuticals, Inc.Advanced Malignancies

Start: 2006-04-30End: 2008-04-30Updated: 2013-09-23